Ligand validation:8WKO

LLP: (2S)-2-amino-6-[[3-hydroxy-2-methyl-5-(phosphonooxymethyl)pyridin-4-yl]methylideneamino]hexanoic acid

LLP is a Ligand Of Interest in 8WKO designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8WKO_LLP_A_503	35%	42%	0.263	0.956	1.02	1.26	3	4	0	0	100%	0.96
8WKO_LLP_B_505	29%	44%	0.282	0.94	1.03	1.19	1	2	0	0	100%	0.96
8WKR_LLP_D_502	58%	51%	0.172	0.952	0.84	1.06	1	2	0	0	100%	0.96
4XG1_LLP_C_504	91%	16%	0.089	0.976	2.19	1.65	5	8	2	0	100%	1
6WNN_LLP_A_501	20%	20%	0.278	0.885	2.3	1.26	3	3	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.